Inventor · disambiguated record
Liming Wang
Also filed as: WANG LIMING
50 granted patents·19 pending applications·215 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
69 records- 0193US6313107B1Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·44 cites·21 claims
- 0292US6380256B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Apr 30, 2002·22 cites·24 claims
- 0389US6369261B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Apr 9, 2002·22 cites·24 claims
- 0486US8623856B2Phenoxy-azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Jan 7, 2014·4 cites·15 claims
- 0586US6387892B1Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2001·Granted May 14, 2002·18 cites·6 claims
- 0685US8853251B2Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseasesALLERGAN INC·Filed 2013·Granted Oct 7, 2014·4 cites·7 claims
- 0785US8492557B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanolCHOW KEN·Filed 2011·Granted Jul 23, 2013·5 cites·12 claims
- 0885US8492422B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditionsDIBAS MOHAMMAD I·Filed 2011·Granted Jul 23, 2013·5 cites·7 claims
- 0985US6495552B2Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN INC·Filed 2001·Granted Dec 17, 2002·16 cites·63 claims
- 1084US8653123B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseasesDIBAS MOHAMMAD I·Filed 2011·Granted Feb 18, 2014·4 cites·7 claims
- 1181US9402912B2Antibiotic conjugates directly linked with steroid drugsALLERGAN INC·Filed 2014·Granted Aug 2, 2016·5 cites·9 claims
- 1281US7226951B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2004·Granted Jun 5, 2007·13 cites·4 claims
- 1381US6387951B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted May 14, 2002·8 cites·11 claims
- 1479US9040532B2Alpha adrenergic receptor modulatorsCHOW KEN·Filed 2010·Granted May 26, 2015·4 cites·14 claims
- 1578US9402913B2Cyclosporine A steroid conjugatesALLERGAN INC·Filed 2014·Granted Aug 2, 2016·4 cites·2 claims
- 1678US8501796B2Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressureDIBAS MOHAMMAD I·Filed 2011·Granted Aug 6, 2013·2 cites·18 claims
- 1777US8518932B2Oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Aug 27, 2013·3 cites·14 claims
- 1876US8969544B2Combined use of PRAME inhibitors and HDAC inhibitorsBERNARDS RENé·Filed 2011·Granted Mar 3, 2015·6 cites·2 claims
- 1976US6855512B2Methods for identifying inhibitors of cytochrome P450RAIALLERGAN INC·Filed 2002·Granted Feb 15, 2005·6 cites·7 claims
- 2074US8906899B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Dec 9, 2014·1 cites·8 claims
- 2173US8729062B2Benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted May 20, 2014·1 cites·8 claims
- 2273US8501726B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Aug 6, 2013·1 cites·8 claims
- 2373US8080570B2α2B and α2C agonistsTAKEUCHI JANET A·Filed 2009·Granted Dec 20, 2011·1 cites·2 claims
- 2472US6603019B21-imidazolyl substituted tetrahydronaphthalene derivatives as inhibitors of eytochrome P450RAIALLERGAN INC·Filed 2002·Granted Aug 5, 2003·4 cites·12 claims
- 2571US7468391B2Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26BALLERGAN INC·Filed 2004·Granted Dec 23, 2008·5 cites·12 claims
- 2670US6740676B24-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activityALLERGAN INC·Filed 2002·Granted May 25, 2004·5 cites·32 claims
- 2769US8754066B2Phenoxy derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Jun 17, 2014·1 cites·13 claims
- 2865US2013289088A1Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressureALLERGAN INC·Filed 2013·Application pending·0 cites
- 2965US2013296394A1Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditionsALLERGAN INC·Filed 2013·Application pending·0 cites
- 3064US8697733B2Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·0 cites·8 claims
- 3164US7928081B2Combined use of PRAME inhibitors and HDAC inhibitorsBERNARDS RENE·Filed 2005·Granted Apr 19, 2011·1 cites·7 claims
- 3264US2014057952A1Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 3363US8492410B2Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Jul 23, 2013·0 cites·8 claims
- 3463US2016354346A1Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditionsALLERGAN INC·Filed 2016·Application pending·0 cites
- 3563US2014213573A1Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3662US9199989B2N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptorsALLERGAN INC·Filed 2014·Granted Dec 1, 2015·0 cites·9 claims
- 3762US2014128369A1Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3861US9034896B2N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptorsALLERGAN INC·Filed 2014·Granted May 19, 2015·0 cites·9 claims
- 3960US8741921B2N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptorsALLERGAN INC·Filed 2013·Granted Jun 3, 2014·0 cites·9 claims
- 4060US8618139B2Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Dec 31, 2013·0 cites·12 claims
- 4160US8399492B2Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Mar 19, 2013·0 cites·8 claims
- 4260US8288555B2Alkene derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Oct 16, 2012·0 cites·11 claims
- 4359US8815861B2N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptorsSINHA SANTOSH C·Filed 2012·Granted Aug 26, 2014·0 cites·12 claims
- 4459US8513419B2N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptorsSINHA SANTOSH C·Filed 2012·Granted Aug 20, 2013·0 cites·11 claims
- 4559US2015148394A1Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditionsALLERGAN INC·Filed 2015·Application pending·0 cites
- 4658US8846728B2Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Sep 30, 2014·0 cites·9 claims
- 4757US2014057878A1Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulatorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 4857US2024385182A1Masked fluorogenic lipid compounds, lipid particles comprising the same, and methods of use thereofUNIV RUTGERS·Filed 2024·Application pending·0 cites
- 4956US8609636B2Oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsFANG WENKUI K·Filed 2011·Granted Dec 17, 2013·0 cites·12 claims
- 5056US7638648B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2007·Granted Dec 29, 2009·0 cites·10 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Liming Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →